Membership of Hypofractionated Radiotherapy Working Group
In 2014, the update was overseen by a multidisciplinary working group convened by Cancer Australia:
- Dr Marie-Frances Burke (Chair) - Radiation Oncologist
- Ms Jan Rice - Breast care nurse
- Dr Kirsty Stuart - Radiation Oncologist
- Dr Patsy Soon - Breast Surgeon
- Ms Bronwyn Wells - Consumer representative
The orginal guideline was developed by a multidisciplinary working group convened by NBOCC [1].
- A/Prof Boon Chua (Chair) - Radiation Oncologist
- Dr Marie-Frances Burke - Radiation Oncologist
- Prof Geoff Delaney - Radiation Oncologist
- Dr Jane O’Brien - Breast Surgeon
- Ms Jan Rice - Breast Care Nurse
- Ms Geraldine Robertson - Consumer Representative
- Dr Kirsty Stuart - Radiation Oncologist
Topic-specific guideline development process
Priority topic areas for guideline development are determined in consultation with key stakeholders including experts in relevant disciplines and consumer representatives. A specific multidisciplinary Working Group, including consumers, is established for each topic identified and is involved in all aspects of guideline development. A systematic evidence review is undertaken for each guideline. All members are asked to declare any conflicts of interest and these declarations are recorded. The content of the guideline is not influenced by any external funding body. The guideline is reviewed externally by key stakeholders and the wider community and endorsement is sought from relevant professional colleges and groups in Australia.
[1] In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.